Ratos's Annual General Meeting will be held on Wednesday, 11 April at 17.30 CET in Berwaldhallen, Stockholm. The complete notice of the meeting is available at www.ratos.se where attendance can also be notified. Complete AGM documentation will be available at Ratos's head office and on the company's website www.ratos.se from 28 March. Board of Directors The Nomination Committee proposes election of Annette Sadolin as a new Board member and re-election of Board members Olof Stenhammar, Lars Berg, Staffan Bohman, Göran Grosskopf, Arne Karlsson (CEO), Jan Söderberg and Per-Olof Söderberg. Peggy Bruzelius has declined re-election. Olof Stenhammar is proposed as Chairman of the Board. Olof Stenhammar is also proposed as Chairman of the AGM. Annette Sadolin, who is proposed for election as a new Board member, has had a long international career within the insurance industry, primarily General Electric. Among other positions, she was a member of the Board and management of General Electric's reinsurance companies in Europe, Asia and the US and was CEO of the Danish company GE Frankona. She retired from GE in 2003 and today sits on the boards of several major companies, including Topdanmark, Dansk Standard and Lindab International AB. Annette Sadolin, who was born in 1947, has a law degree from Copenhagen University. She lives in Copenhagen. Of the proposed Board members, all except Olof Stenhammar, who has been on the Board of the company for more than 12 years, and the company's CEO Arne Karlsson are independent of Ratos and its management. Two Board members, Jan Söderberg and Per-Olof Söderberg, are non-independent of major shareholders. A more detailed presentation of proposed Board members and the work of the Nomination Committee is provided on the company's website www.ratos.se. Proposed dividend The Board proposes an ordinary dividend of SEK 5.50 per share (4.19) of class A and B. In addition, an extra dividend is proposed of SEK 5.50 per class A and B share. The record date for the right to received dividends is proposed as 16 April and dividends are expected to be paid on 19 April. Purchase of treasury shares The Board of Directors proposes that the Annual General Meeting gives the Board a mandate to decide, during the period until the next Annual General Meeting, on repurchase of a maximum number of shares so that the company's holding of treasury shares does not exceed 7% of all the shares in the company. The purpose of the buy-backs is to give the Board more room for manoeuvre in its work to create value for the company's shareholders. Incentive programme The Board proposes a decision to issue a maximum of 775,000 call options on repurchased Ratos-shares to be transferred at a market premium to key people within Ratos. The intention is that option purchases should be partly subsidised. It is further proposed that the Annual General Meeting decides on a transfer of a maximum of 775,000 shares in the company when the above-mentioned options are exercised. In addition, the Board proposes that the Annual General Meeting decides to introduce a cash-settled option programme related to Ratos's investments in new holdings. It is proposed to carry out the programme through issuance of synthetic options which key people within Ratos will be entitled to acquire. For further information, please contact: Olof Stenhammar, Chairman of the Board, +46 8 700 17 45 Financial calendar from Ratos: Annual General Meeting 11 April 2007 Interim report January-March 9 May 2007 Interim report January-June 21 August 2007 Interim report January-September 9 November 2007 Ratos is a listed private equity company. The business concept is to maximise shareholder value over time by investing in, developing and divesting primarily unlisted companies. Ratos thus offers stock market players a unique investment opportunity. The equity of Ratos's investments is approximately SEK 11 billion. Ratos's holdings include Anticimex, Arcus Gruppen, Bisnode, Bluegarden, Camfil, DIAB, GS-Hydro, Haendig, Haglöfs, HL Display, Hägglunds Drives, Inwido, Jøtul, Lindab, Medifiq Healthcare, RH/RBM, Superfos and Other holdings.